Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Douglas A. McIntyre | Mar 17, 2008 at 5:17 AM EDT

Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion

Bristol-Myers (NYSE: BMY) does not see much future in baby food. It is trying to sell its operation to a…

Douglas A. McIntyre | Mar 16, 2008 at 11:49 AM EDT

Bleak House: Despair On The 52-Week Low List (GE)(VZ)(GOOG)(C)

Those rummaging through the garbage of 52-week low lists are usually bottom-fishing investors or desperate CEOs. But, the list is…

Douglas A. McIntyre | Mar 14, 2008 at 4:44 AM EDT

Auction-Rate Securities Hit Mid-Cap Companies

Some large companies, like Bristol-Myers (BMY), has already said that auction-rate securities on their balance sheets may have to be…

Douglas A. McIntyre | Mar 12, 2008 at 12:59 PM EDT

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

CyDex Pharmaceuticals, Inc. has filed to come public via an IPO in what it lists for filing purposes as up…

Douglas A. McIntyre | Jan 7, 2008 at 11:46 PM EST

Cramer Chooses Among Dogs of Dow For Appreciation & Preservation (DOW, VZ, T, MO, BMY)

On tonight’s MAD MONEY on CNBC, Jim Cramer wanted to look for stocks with both appreciation potential that also offer…

Douglas A. McIntyre | Dec 17, 2007 at 10:49 AM EST

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks…

Douglas A. McIntyre | Dec 10, 2007 at 4:57 PM EST

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the…

Douglas A. McIntyre | Dec 6, 2007 at 4:10 AM EST

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

According to Reuters, Nikon is seeing a sharp increase in demand from LCD makers. Reuters writes that the housing slump…

Douglas A. McIntyre | Dec 5, 2007 at 12:33 PM EST

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today. All of the talk up…

Douglas A. McIntyre | Nov 4, 2007 at 5:28 PM EST

A Little Trouble For Bristol-Myers (BMY) Plavix

Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4…

Douglas A. McIntyre | Oct 17, 2007 at 7:51 AM EDT

Medarex Hit With Sell Rating (MEDX, BMY)

Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL"…

Douglas A. McIntyre | Oct 12, 2007 at 1:05 PM EDT

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

We were screening options activity today and something came up that where bets had significantly grown from our prior coverage. …

Douglas A. McIntyre | Oct 8, 2007 at 3:17 AM EDT

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Morgan Stanley (MS) plans to start a wealth management business in India. Reuters writes that Alan Greenspan…

Douglas A. McIntyre | Sep 25, 2007 at 3:08 AM EDT

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Microsoft (MSFT) launched its Halo 3 game which is essential to driving Xbox sales. Reuters writes that…

Douglas A. McIntyre | Sep 11, 2007 at 7:22 AM EDT

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Shares of Imclone Systems Inc. (NASDAQ:IMCL) are screaming higher this morning on it meeting its primary endpoint of increasing survival…

1 … 36 37 38 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion

Bleak House: Despair On The 52-Week Low List (GE)(VZ)(GOOG)(C)

Auction-Rate Securities Hit Mid-Cap Companies

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

Cramer Chooses Among Dogs of Dow For Appreciation & Preservation (DOW, VZ, T, MO, BMY)

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers (BMY) Looks To Sell Baby Food Business For As Much As $9 Billion

Bleak House: Despair On The 52-Week Low List (GE)(VZ)(GOOG)(C)

Auction-Rate Securities Hit Mid-Cap Companies

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

Cramer Chooses Among Dogs of Dow For Appreciation & Preservation (DOW, VZ, T, MO, BMY)

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Media Digest 12/6/2007 Reuters, WSJ, NYTimes, FT, Barrons’

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s